July 9 (Reuters) - Novartis AG:
* SIRONAX: GRANTS NOVARTIS EXCLUSIVE OPTION TO ACQUIRE ITS
BRAIN
DELIVERY PLATFORM WHILE RETAINING RIGHTS TO ADVANCE SELECTED
THERAPEUTIC ASSETS
* SIRONAX: SIRONAX IS ELIGIBLE TO RECEIVE UP TO $175 MILLION
IN
UPFRONT AND NEAR-TERM PAYMENTS UNDER AGREEMENT
* SIRONAX: UNDER AGREEMENT, NOVARTIS TO EVALUATE BDM
PLATFORM
WITHIN OPTION PERIOD
Source text:
Further company coverage: